| Literature DB >> 25970587 |
Abstract
Since its discovery and characterization in the early 1960s (Hurwitz, J. The discovery of RNA polymerase. J. Biol. Chem. 2005, 280, 42477-42485), an enormous amount of biochemical, biophysical and genetic data has been collected on bacterial RNA polymerase (RNAP). In the late 1990s, structural information pertaining to bacterial RNAP has emerged that provided unprecedented insights into the function and mechanism of RNA transcription. In this review, I list all structures related to bacterial RNAP (as determined by X-ray crystallography and NMR methods available from the Protein Data Bank), describe their contributions to bacterial transcription research and discuss the role that small molecules play in inhibiting bacterial RNA transcription.Entities:
Keywords: NMR; X-ray crystallography; anti-σ factor; bacterial RNA polymerase; core enzyme; holoenzyme; inhibitor antibiotic; transcription; transcription factor; σ factor
Mesh:
Substances:
Year: 2015 PMID: 25970587 PMCID: PMC4496699 DOI: 10.3390/biom5020848
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1RNAP assembly and transcription cycle. The figure shows the general scheme for bacterial RNAP assembly and the transcription cycle. PDB codes of RNAP structures (in brackets) belonging to each phase of the transcription cycle.
Figure 2(a) Three-dimensional representation of the interaction between RNAP and transcription factors. The E. coli RNAP holoenzyme is shown as a molecular surface representation (α subunits: white; β subunit: cyan; β’ subunit: pink; ω subunit: gray; σ70: orange; σ region 1.1: red). Transcription factors binding sites are indicated in double quotation marks and PDB codes of structures are shown in brackets; (b) Three-dimensional representation of the interaction between σ and anti-σ factors. E. coli RNAP holoenzyme is shown as a molecular surface representation, and only the core enzyme is partially transparent (α subunits: white; β subunit: cyan; β’ subunit: pink; ω subunit: gray; σ70: orange). Targets of anti-σ factors are indicated in double quotation marks and PDB codes of structures are shown in brackets.
Structural information on bacterial RNAP.
| Structure | PDB code | Reference | Source |
|---|---|---|---|
| Subunit and domain | |||
| α subunit NTD | 1BDFX | [ | A |
| α subunit NTD | 4NOIX | none | F |
| α subunit CTD | 1COON, 3K4GX | [ | A |
| α subunit CTD | 1DOQN | [ | B |
| α subunit CTD | 2MAXN | [ | E |
| β subunit 2/i4 domains | 3LTIX | [ | A |
| β subunit flap domain | 2LY7N | none | C |
| β subunit 1/2 domains | 4KBJX | [ | I |
| β' subunit i2 domain | 2AUJX | [ | B |
| β' subunit i6 domain | 2AUKX, 4IQZX | [ | A |
| σ region 1.1 | 2K6XN | [ | G, a |
| σ70 domain2 | 1SIGX | [ | A, a |
| σA domains2 and 3 | 1KU2X | [ | B, a |
| σA domain4 | 1KU3X | [ | B, a |
| σA domain4–DNA (−35 element) | 1KU7X | [ | B, a |
| σA domain4 | 1TTYN | [ | G, a |
| σA domain2–DNA (−10 element) | 3UGOX, 3UGPX | [ | B, a |
| σA domain4–αCTD–DNA | 3N97X | none | B, a, A |
| σNRpoN–DNA (−24 element) | 2O8KN, 2O9LN | [ | D, d |
| σN core binding domain | 2K9MN | [ | D, d |
| σNRpoN domain | 2AHQN | [ | D, d |
| σEdomain4–DNA (−35 element) | 2H27X | [ | A, c |
| σC domain2 | 2O7GX | [ | I, c |
| σC domain4 | 2O8XX | [ | I, c |
| σD domain4 | 3VFZX | [ | I, c |
| δ subunit NTD | 2KRCN, 4NC7X, 4NC8X, 2M4KN, 2KRCN | [ | C |
| ε subunit | 4NJCX | [ | C |
| RNAP | |||
| Core enzyme | 1HQMX | [ | B |
| Core enzyme (Δω subunit) | 2GHOX | [ | B |
| Holoenzyme | 1L9UX, 1IW7X, 2A6EX, 2CW0X | [ | B |
| Holoenzyme | 4YG2X, 4LJZX, 4MEYX | [ | A |
| Holoenzyme–DNA (−41 ~ −7) | 1L9ZX | [ | B |
| Holoenzyme–DNA (−12 ~ +12) | 4G7HX, 4G7OX | [ | B |
| 4Q4ZX, 4OIOX | [ | B | |
| Initially transcribing complex | 4Q5SX | [ | B |
| Elongation complex | 2O5IX, 2O5JX | [ | B |
| Paused elongation complex | 4GZYX, 4GZZX | [ | B |
| Backtracked elongation complex | 4WQSX | [ | B |
A: Escherichia coli; B: Thermus aquatics/Thermus thermophilus; C: Bacillus subtilis/Bacilus stearothermophilus; D: Aquifex aeolicus; E: Helicobacter pylori; F: Campylobacter jejuni; G: Thermotoga maritime; I: Mycobacterium tuberculosis; a: group I σ factor; c: extracytoplasmic function (ECF) σ factor; d: σN/σ54 factor; X: X-ray crystallography method; N: NMR method.
Structural information on bacterial RNAP and transcription factor complexes.
| Structure | PDB | References | Source |
|---|---|---|---|
| σ/anti-σ complex | |||
| σF domains2, 3, 4/FlgM | 1SC5X, 1RP3X | [ | D, b |
| σE domains2, 4/ChrR | 2Z2SX, 2Q1ZX | [ | J, c |
| σE domains2, 4/RseA | 1OR7X | [ | A, c |
| σK domains2, 4/RskA | 4NQWX | [ | I, c |
| σF domain3/SpoIIAB | 1L0OX | [ | C, b |
| σ70 domain4/Rsd | 2P7VX | [ | A, a |
| σD domain4/RsdA | 3VEPX | [ | I, c |
| σL domain4/RslA | 3HUGX | [ | I, c |
| Transcription factor complex | |||
| αCTD–CAP–DNA | 1LB2X, 3N4MX | [ | A |
| αCTD–Spx | 1Z3EX, 3GFKX, 3IHQX | [ | C |
| αCTD–NusA (AR2) | 2JZBN | none | H, A |
| β subunit 1/2 domains–CarD | 4KBMX | [ | I |
| β subunit 1 domain–TRCF | 3MLQX | [ | B |
| σA domain4–λcI–DNA | 1RIOX | [ | B |
| σ70 domain4–PhoB–β flap–DNA | 3T72X | [ | A |
| Holoenzyme–CAP–DNA | 3IYDC | [ | A |
| Core enzyme–GreA/Gfh1 | 4WQTX | [ | B |
| Elongation complex–Gfh1 | 3AOHX, 3AOIX | [ | B |
| Elongation complex –RapA | 4S20X | [ | A |
| Phage factor complex | |||
| Holoenzyme–gp2 | 4LK0X, 4LLGX | [ | A |
| β' subunit jaw domain–gp2 | 2LMCN | [ | A |
| β subunit flap domain–gp33 | 3TBIX | [ | A |
| Holoenzyme–gp39 | 3WODX | [ | B |
| β subunit flap domain –gp39 | 3WOFX, 3WOEX | [ | B |
| σ70 domain4–AsiA | 1TLHN | [ | A, a |
| σA domain4–gp67 | 4G8XX | [ | K, a |
A: Escherichia coli; B: Thermus aquatics/Thermus thermophilus; C: Bacillus subtilis/Bacilus stearothermophilus; D: Aquifex aeolicus; H: Yersinia pseudotuberculosis; I: Mycobacterium tuberculosis; K: Staphyloccus aureus; a: group I σ factor; b: group II σ factor; c: extracytoplasmic function (ECF) σ factor; X: X-ray crystallography method; C: Cryo-EM single-particle analysis method; N: NMR method.
Structural information on bacterial RNAP and small molecule inhibitor complexes *.
| Structure | PDB | Reference | Source |
|---|---|---|---|
| Core enzyme–rifampin | 1YNN | [ | B |
| Holoenzyme–rifampin | 4KMU | [ | A |
| Holoenzyme–rifampin derivatives | 2A68, 2A69 | [ | B |
| Holoenzyme–rifampin derivatives | 4KN4, 4KN7 | [ | A |
| Holoenzyme–ppGpp | 1SMY | [ | B |
| Holoenzyme–ppGpp | 4JK1, 4JKR | [ | A |
| Holoenzyme–pppGpp | 4JK2 | [ | A |
| Core enzyme–sorangicin | 1YNJ | [ | B |
| Holoenzyme–streptolydigin | 1ZYR, 2A6H | [ | B |
| Elongation complex–streptolydigin | 2PPB | [ | B |
| Holoenzyme–myxopyronin | 3DXJ, 3EQL | [ | B |
| Holoenzyme–myxopyronin | 4YFX | [ | A |
| Holoenzyme–GE23077 | 4MQ9 | [ | B |
| Holoenzyme–DNA–GE23077 | 4OIN, 4OIP | [ | B |
| Holoenzyme–DNA–GE23077/rifamycin SV | 4OIR | [ | B |
| Holoenzyme–salinamide A | 4MEX | [ | A |
| Holoenzyme–squaramide | 4YFK, 4YFN | [ | A |
A: Escherichia coli; B: Thermus aquatics/Thermusthermophilus; * All structures in this table were determined by X-ray crystallography method.
Figure 3Three-dimensional representation of targets of small-molecule RNAP inhibitors. E. coli RNAP holoenzyme is depicted as an α-carbon backbone traced with partially transparent molecular surfaces (α subunits: white; β subunit: cyan; β' subunit: pink; ω subunit: gray; σ70: orange). Small-molecule inhibitors bound to RNAP are depicted as CPK models. Chemical structures of small-molecule inhibitors and mechanisms of transcription inhibition are indicated.